Literature DB >> 25408270

The vulnerable myocardium. Diabetic cardiomyopathy.

H Bugger1, C Bode.   

Abstract

Cardiovascular disease is the major cause of morbidity and mortality in subjects suffering from diabetes mellitus. While coronary artery disease is the leading cause of cardiac complications in diabetics, it is widely recognized that diabetes increases the risk for the development of heart failure independently of coronary heart disease and hypertension. This increased susceptibility of the diabetic heart to develop structural and functional impairment is termed diabetic cardiomyopathy. The number of different mechanisms proposed to contribute to diabetic cardiomyopathy is steadily increasing and underlines the complexity of this cardiac entity. In this review the mechanisms that account for the increased myocardial vulnerability in diabetic cardiomyopathy are discussed.

Entities:  

Keywords:  Diabetes; cardiomyopathy; energy metabolism; mitochondria

Mesh:

Substances:

Year:  2014        PMID: 25408270     DOI: 10.5482/HAMO-14-09-0038

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  8 in total

1.  Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.

Authors:  Mingge Ding; Qianqian Dong; Zhenghua Liu; Zheng Liu; Yinxian Qu; Xing Li; Cong Huo; Xin Jia; Feng Fu; Xiaoming Wang
Journal:  Cardiovasc Diabetol       Date:  2017-02-07       Impact factor: 9.951

2.  Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice.

Authors:  Bin Wu; Jie Lin; Jian Luo; Dong Han; Miaomiao Fan; Tao Guo; Ling Tao; Ming Yuan; Fu Yi
Journal:  Biomed Res Int       Date:  2017-03-21       Impact factor: 3.411

3.  Quercetin Prevents Diastolic Dysfunction Induced by a High-Cholesterol Diet: Role of Oxidative Stress and Bioenergetics in Hyperglycemic Rats.

Authors:  Rodrigo L Castillo; Emilio A Herrera; Alejandro Gonzalez-Candia; Marjorie Reyes-Farias; Nicole de la Jara; Juan Pedro Peña; Catalina Carrasco-Pozo
Journal:  Oxid Med Cell Longev       Date:  2018-01-11       Impact factor: 6.543

4.  Activation of AMPK/p38/Nrf2 is involved in resveratrol alleviating myocardial ischemia-reperfusion injury in diabetic rats as an endogenous antioxidant stress feedback.

Authors:  Guiping Xu; Yankai Ma; Jing Jin; Xiaoli Wang
Journal:  Ann Transl Med       Date:  2022-08

Review 5.  Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives.

Authors:  Luis E León; Sweta Rani; Mauricio Fernandez; Martín Larico; Sebastián D Calligaris
Journal:  J Diabetes Res       Date:  2015-12-06       Impact factor: 4.011

6.  Cardiac dysfunction is attenuated by ginkgolide B via reducing oxidative stress and fibrosis in diabetic rats.

Authors:  Yu-Xin Jiang; Wei Li; Jing Wang; Guo-Guang Wang
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

7.  High cardiovascular risk of patients with type 2 diabetes is only partially attributed to angiographic burden of atherosclerosis.

Authors:  Simone Battermann; Andrea Milzi; Rosalia Dettori; Kathrin Burgmaier; Nikolaus Marx; Mathias Burgmaier; Sebastian Reith
Journal:  Diab Vasc Dis Res       Date:  2020 Sep-Oct       Impact factor: 3.291

Review 8.  Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy.

Authors:  Xiangyu Ke; Zhirui Lin; Zebing Ye; Meifang Leng; Bo Chen; Chunjie Jiang; Xiaoyun Jiang; Guowei Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-22       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.